COVID-19 Manufacturing & Supply Chain SARS-CoV-2 Vaccine Development Vaccine Development Vaccine Outreach to Developing Economies

Kenya Will Build A Vaccine Manufacturing Plant In Nairobi Worth USD 17 Million

by Roohi : Leave a comment

Kenya Will Build A Vaccine Manufacturing Plant In Nairobi Worth USD 17 Million Kenya will spend USD 17 million billion to build a vaccine production plant. According to Health Cabinet Secretary Mutahi Kagwe, the company, Kenya Biovax Limited will begin operations as a “fill and finish” plant under the Ministry of Health in the next […]

Manufacturing & Supply Chain Uncategorised Vaccine Development

A Selection of Australian mRNA Vaccine Manufacturers is likely in the Coming Days

by Roohi : Leave a comment

A Selection of Australian mRNA Vaccine Manufacturers is likely in the Coming Days According to Federal Health Minister Greg Hunt, the federal government is nearing completion of a shortlist of firms to manufacture mRNA vaccines in Australia. Australia presently imports all mRNA vaccines, including those from Pfizer, and only produces AstraZeneca dosages in-house. On May […]

Uncategorised

GAVI Praises Efficient Vaccine Response in India

by Roohi : Leave a comment

GAVI Praises Efficient Vaccine Response in India Commenting on the reason for India’s success in reaching a billion vaccinations, Deputy GAVI CEO Anuradha Gupta remarked that India has a huge advantage coming out of systematic investments that have been made in strengthening public health systems since 2005, under the National Health Mission, previously National Rural […]

Manufacturing & Supply Chain Vaccine Development Vaccine Outreach to Developing Economies

Philippines Looks to Overcome Vaccine Distribution Hurdles

by Roohi : Leave a comment

Philippines Looks to Overcome Vaccine Distribution Hurdles The supply of COVID-19 vaccines is no longer an issue, but vaccine czar Carlito Galvez Jr. also admitted that distribution remains a challenge seven months into the national vaccination program. Galvez said the country has so far received over 20.2 million doses this month alone. It is the […]

SARS-CoV-2 Vaccine Development

Moderna and J&J Covid Vaccination Boosters Have Been Approved by The CDC, Allowing Patients to Mix and Match Injections

by Roohi : Leave a comment

Moderna and J&J Covid Vaccination Boosters Have Been Approved by The CDC, Allowing Patients to Mix and Match Injections The CDC allowed booster shots of Moderna’s and Johnson & Johnson’s Covid-19 vaccines late Thursday, allowing individuals in the U.S. to mix and match any of the three vaccinations approved for use, according to a statement […]

SARS-CoV-2 Vaccine Development Vaccines Partnerships & Collaborations

GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19

by Roohi : Leave a comment

The European Medicines Agency (EMA) has begun a review of an investigational, dual-action SARS-COV-2 monoclonal antibody called VIR-7831 (GSK4182136), jointly developed by GlaxoSmithKline plc and Vir Biotechnology, Inc. to treat adults and adolescents with COVID-19 who are at high risk of progressing to severe COVID-19 but do not require oxygen supplementation….

SARS-CoV-2 Vaccine Development

All Californians 16+ Now Eligible for COVID-19 Vaccines

by Roohi : Leave a comment

Following major milestones in its vaccination programme, with almost half its population aged 16 and up and 73.9% of seniors over 65 having received one dose, all residents of the state of California ages 16 and above have become eligible for COVID-19 vaccinations as of April 15th. This decision meets President Biden’s nationwide deadline for all adults in the U.S. to be eligible to receive the COVID-19 vaccine by April 19th….

Regulatory Challenges SARS-CoV-2 Vaccine Development

Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine

by Roohi : Leave a comment

A rare and critical type of blood clot called cerebral venous sinus thrombosis (CVST) has been detected in combination with low levels of blood platelets (thrombocytopenia) in six women between the ages of 18 and 48, 6 to 13 days after they received doses of the Johnson & Johnson (Janssen) vaccine in U.S. More than 6.8 million doses of the J&J vaccine have been administered in the U.S. as of April 12th….